Portal vein thrombosis associated with a myeloproliferative disorder, prothrombin G20210A mutation, antiphospholipid syndrome, with repermeation during anticoagulant therapy;Thrombose portale récente régressive sous anticoagulants secondaire à un syndrome myéloprolifératif latent, une mutation G20210A du gène de la prothrombine et un syndrome des antiphospholipides

Gastroenterologie Clinique et Biologique

Volumn 25, Issue 5, 2001, Pages 549-551

  Diaz, Emmanuel ^a   Nahon, Stéphane ^a   Charachon, Antoine ^a   Traissac, Laurent ^a   Lenoble, Martine ^a   Challier, Emmanuel ^a   Delas, Nicolas ^a  

^a Centre Hospitalier Intercommunal Le Raincy Montfermeil   (France)

Author keywords

Anticoagulation; Antiphospholipid syndrome; Factor II G202101 mutation; Myeloproliferative disorder; Portal vein thrombosis

Indexed keywords

ANTICOAGULANT AGENT; PROTHROMBIN;

AGED; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; LIVER CELL CARCINOMA; MALE; MYELOPROLIFERATIVE DISORDER; PORTAL VEIN THROMBOSIS; SPLENIC VEIN;

AGED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; HUMANS; MALE; MUTATION; MYELOPROLIFERATIVE DISORDERS; PORTAL VEIN; PROTHROMBIN; SPLENIC VEIN; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS;

EID: 0034897570     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Conduite à tenir devant une thrombose de la veine porte
2. Portal vein thrombosis in adults: Pathophysiology, pathogenesis and management
3. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders
4. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
5. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
6. La transition G20210A dans le gène de la prothrombine et la maladie thromboembolique veineuse
7. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
8. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis
9. Anticorps antiphospholipides: Limites et utilisation potentielle au cours des maladies du foie
10. Antiphospholipid antibodies and thrombosis
11. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop
12. Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy
13. Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy